Contact
searchSearch
HMP Global

Psych Congress Network

Latest News, Insights, and Quizzes

California Society of Addiction Medicine (CSAM) Logo
Conference Coverage
Buprenorphine Sessions to Watch at the CSAM 2026 Annual Conference
10/22/2026
Brionna Mendoza
Practical approaches to initiating buprenorphine and navigating overlapping pain and opioid dependence are among the topics planned for the CSAM Annual Conference, held October 21–24, 2026, in Garden Grove, California.
Practical approaches to initiating buprenorphine and navigating overlapping pain and opioid dependence are among the topics planned for the CSAM Annual Conference, held October 21–24, 2026, in Garden Grove, California.
Practical approaches to...
10/22/2026
Psych Congress Network
Mariela Podolski, MD, and James Somers, PA-C, DHSc, DFAAPA
Videos
Exploring the Biological Role of Nutrition in Mental Health Care
10/22/2026
Mariela Podolski, MD; James C. Somers, DHSc, PA-C, DFAAPA
Psych Congress faculty members Mariela Podolski, MD, and James Somers, PA-C, DHSc, DFAAPA, discuss the relationship between nutrition and psychiatric outcomes.
Psych Congress faculty members Mariela Podolski, MD, and James Somers, PA-C, DHSc, DFAAPA, discuss the relationship between nutrition and psychiatric outcomes.
Psych Congress faculty members...
10/22/2026
Psych Congress Network
3D illustration of a brain in blue and white against a black background
Research Summary
Home Depression Protocol Proves Feasible but Shows No Added Benefit
10/21/2026
Brionna Mendoza
Home transcranial direct current stimulation paired with cognitive training delivered through a video game was feasible but offered no superior antidepressant benefit in a randomized clinical trial published in JAMA Network Open.
Home transcranial direct current stimulation paired with cognitive training delivered through a video game was feasible but offered no superior antidepressant benefit in a randomized clinical trial published in JAMA Network Open.
Home transcranial direct current...
10/21/2026
Psych Congress Network
a woman pours a pill from a pill bottle into her hand
Research Summary
Meta-Analysis Finds No Clear Sex Differences in Antipsychotic Efficacy
10/15/2026
Maria Mantas
An individual participant data meta-analysis of 18 fixed-dose trials involving 7062 adults with acute schizophrenia found no evidence of sex differences in antipsychotic efficacy for overall symptom improvement.
An individual participant data meta-analysis of 18 fixed-dose trials involving 7062 adults with acute schizophrenia found no evidence of sex differences in antipsychotic efficacy for overall symptom improvement.
An individual participant data...
10/15/2026
Psych Congress Network
Rakesh Jain, MD, MPH
Quiz
Common Missteps in Sleep Care
10/13/2026
Maria Mantas
According to an interview with Rakesh Jain, MD, MPH, what is a common mistake clinicians make when evaluating sleep complaints in patients with psychiatric disorders?
According to an interview with Rakesh Jain, MD, MPH, what is a common mistake clinicians make when evaluating sleep complaints in patients with psychiatric disorders?
According to an interview with...
10/13/2026
Psych Congress Network
illustration of a laptop screen displaying a test
Quiz
Biomarker-Consistent Antidepressant Selection
10/13/2026
Maria Mantas
Can you recall how biomarker-consistent antidepressant treatment compared to biomarker-inconsistent treatment?
Can you recall how biomarker-consistent antidepressant treatment compared to biomarker-inconsistent treatment?
Can you recall how...
10/13/2026
Psych Congress Network
a rubber stamp says "FDA Approved"
FDA Alerts
FDA Approves Monthly Olanzapine LAI for Adults With Schizophrenia
10/09/2026
Brionna Mendoza
Teva Pharmaceuticals announced the FDA approval of subcutaneous olanzapine (Weltruza) for extended-release injectable suspension on October 9, 2026.
Teva Pharmaceuticals announced the FDA approval of subcutaneous olanzapine (Weltruza) for extended-release injectable suspension on October 9, 2026.
Teva Pharmaceuticals announced...
10/09/2026
Psych Congress Network
Head in profile with brain visible and target over brain
Research Summary
Structural Connectivity–Guided iTBS Improves Early Depression Outcomes
10/08/2026
Brionna Mendoza
A connectivity-guided approach to accelerated iTBS produced greater short-term reductions in depression severity than conventional scalp-based targeting.
A connectivity-guided approach to accelerated iTBS produced greater short-term reductions in depression severity than conventional scalp-based targeting.
A connectivity-guided approach...
10/08/2026
Psych Congress Network
US FDA building
FDA Alerts
FDA Authorizes First Digital Therapeutic for Negative Symptoms of Schizophrenia
10/08/2026
Maria Mantas
The US Food and Drug Administration (FDA) granted 510(k) clearance for Motivista, the first treatment specifically authorized for negative symptoms of schizophrenia in adults.
The US Food and Drug Administration (FDA) granted 510(k) clearance for Motivista, the first treatment specifically authorized for negative symptoms of schizophrenia in adults.
The US Food and Drug...
10/08/2026
Psych Congress Network
an illustration of a man sitting on the ground holding his head with his profile and brain in the background
Research Summary
Only 19.1% of First-Episode Psychosis Patients Adhere to Antipsychotics
10/06/2026
Brionna Mendoza
Young people beginning antipsychotic treatment after first-episode psychosis had low medication adherence, according to a retrospective US cohort study published in JAMA Network Open.
Young people beginning antipsychotic treatment after first-episode psychosis had low medication adherence, according to a retrospective US cohort study published in JAMA Network Open.
Young people beginning...
10/06/2026
Psych Congress Network
Kevin Williams, MS, MPAS, PA-C
Videos
Engaging Patients and Care Partners in Tardive Dyskinesia Assessment
10/05/2026
Kevin Williams, MS, MPAS, PA-C
Psych Congress PA Institute Co-Chair Kevin Williams, MS, MPAS, PA-C, explores how clinicians may incorporate the caregiver perspective into TD treatment, particularly when patients are unaware of their symptoms.
Psych Congress PA Institute Co-Chair Kevin Williams, MS, MPAS, PA-C, explores how clinicians may incorporate the caregiver perspective into TD treatment, particularly when patients are unaware of their symptoms.
Psych Congress PA Institute...
10/05/2026
Psych Congress Network

Latest Expert Insights

Mariela Podolski, MD, and James Somers, PA-C, DHSc, DFAAPA
Videos
Exploring the Biological Role of Nutrition in Mental Health Care
10/22/2026
Mariela Podolski, MD; James C. Somers, DHSc, PA-C, DFAAPA
Psych Congress faculty members Mariela Podolski, MD, and James Somers, PA-C, DHSc, DFAAPA, discuss the relationship between nutrition and psychiatric outcomes.
Psych Congress faculty members Mariela Podolski, MD, and James Somers, PA-C, DHSc, DFAAPA, discuss the relationship between nutrition and psychiatric outcomes.
Psych Congress faculty members...
10/22/2026
Psych Congress Network
Kevin Williams, MS, MPAS, PA-C
Videos
Engaging Patients and Care Partners in Tardive Dyskinesia Assessment
10/05/2026
Kevin Williams, MS, MPAS, PA-C
Psych Congress PA Institute Co-Chair Kevin Williams, MS, MPAS, PA-C, explores how clinicians may incorporate the caregiver perspective into TD treatment, particularly when patients are unaware of their symptoms.
Psych Congress PA Institute Co-Chair Kevin Williams, MS, MPAS, PA-C, explores how clinicians may incorporate the caregiver perspective into TD treatment, particularly when patients are unaware of their symptoms.
Psych Congress PA Institute...
10/05/2026
Psych Congress Network
Kevin Williams, MS, MPAS, PA-C
Videos
Engaging Patients and Care Partners in Tardive Dyskinesia Assessment
10/05/2026
Kevin Williams, MS, MPAS, PA-C
Psych Congress PA Institute Co-Chair Kevin Williams, MS, MPAS, PA-C, explores how clinicians may incorporate the caregiver perspective into TD treatment, particularly when patients are unaware of their symptoms.
Psych Congress PA Institute Co-Chair Kevin Williams, MS, MPAS, PA-C, explores how clinicians may incorporate the caregiver perspective into TD treatment, particularly when patients are unaware of their symptoms.
Psych Congress PA Institute...
10/05/2026
Psych Congress Network
Kristian Dambrino, DNP, PMHNP-BC
Conference Insights
Refining the Diagnosis When MDD Treatment Falls Short
10/05/2026
Kristian Dambrino, DNP, PMHNP, MSN
Kristian Dambrino, DNP, PMHNP-BC, offers a framework for pinpointing when antidepressant nonresponse in MDD may be a byproduct of misdiagnosis.
Kristian Dambrino, DNP, PMHNP-BC, offers a framework for pinpointing when antidepressant nonresponse in MDD may be a byproduct of misdiagnosis.
Kristian Dambrino, DNP,...
10/05/2026
Psych Congress Network
Michael Asbach, DMsc, PA-C
Conference Insights
Rethinking MDD Through Glutamate and Neuroplasticity
09/22/2026
Michael Asbach, DMSc, PA-C
Michael Asbach, DMSc, PA-C, Clinical Editor, Psych Congress Journal, explores key concepts from his Psych Congress 2026 session, “Could Glutamatergic Modulation be the Keystone of Durable Change in Treatment-Resistant Depression?”
Michael Asbach, DMSc, PA-C, Clinical Editor, Psych Congress Journal, explores key concepts from his Psych Congress 2026 session, “Could Glutamatergic Modulation be the Keystone of Durable Change in Treatment-Resistant Depression?”
Michael Asbach, DMSc, PA-C,...
09/22/2026
Psych Congress Network
Vladimir Maletic presents on stage
Videos
Dr Vladimir Maletic Memorial Scholarship Recipient Reflects on His Legacy of Compassionate, Patient-Centered Care
09/19/2026
The Dr Vladimir Maletic Memorial Scholarship was established to honor the life, legacy, and lasting influence of Dr Vladimir Maletic, a beloved member of the Psych Congress community and exceptional clinician and educator.
The Dr Vladimir Maletic Memorial Scholarship was established to honor the life, legacy, and lasting influence of Dr Vladimir Maletic, a beloved member of the Psych Congress community and exceptional clinician and educator.
The Dr Vladimir Maletic Memorial...
09/19/2026
Psych Congress Network
Julie Carbray, PhD, PMHNP-BC, and James Greenblatt, MD
Videos
First-Line Decisions in ADHD: Lifestyle Modification or Medication?
09/18/2026
Julie Carbray PhD, PMHNP-BC, PMHCNS-BC, FAAN; James Greenblatt, MD
Julie Carbray, PhD, PMHNP-BC, FAAN, and James Greenblatt, MD, discuss how functional impairment, symptom severity, patient preferences, life stage, and family perspectives can shape initial ADHD treatment decisions, as explored at their 2026...
Julie Carbray, PhD, PMHNP-BC, FAAN, and James Greenblatt, MD, discuss how functional impairment, symptom severity, patient preferences, life stage, and family perspectives can shape initial ADHD treatment decisions, as explored at their 2026...
Julie Carbray, PhD, PMHNP-BC,...
09/18/2026
Psych Congress Network
Jain, Kempf, Albright, and Williams
Podcasts
Beyond “Feeling Better”: Expert Approaches to MDD Management
08/26/2026
Saundra Jain, MA, PsyD, LPC; Brittany B. Albright, MD, MPH; Brooke Kempf, MSN, PMHNP-BC; Kevin Williams, MS, MPAS, PA-C
In this expert Q&A, leading psychiatry clinicians explore how residual symptoms such as anhedonia, anxiety, and suicidality can inform treatment decisions and why clinicians should look beyond a simple assessment of response.
In this expert Q&A, leading psychiatry clinicians explore how residual symptoms such as anhedonia, anxiety, and suicidality can inform treatment decisions and why clinicians should look beyond a simple assessment of response.
In this expert Q&A, leading...
08/26/2026
Psych Congress Network
James Greenblatt, MD
Videos
Incorporating Integrative Approaches Into Psychiatric Care
08/05/2026
James Greenblatt, MD
James Greenblatt, MD, discusses where lifestyle, nutritional, and functional medicine strategies may help address gaps in conventional psychiatric care.
James Greenblatt, MD, discusses where lifestyle, nutritional, and functional medicine strategies may help address gaps in conventional psychiatric care.
James Greenblatt, MD, discusses...
08/05/2026
Psych Congress Network
Psych Congress expert faculty
Podcasts
Balancing Efficacy and Tolerability in MDD Augmentation
07/28/2026
Saundra Jain, MA, PsyD, LPC; Brittany B. Albright, MD, MPH; Julie A. Carbray, PhD, APRN; Philip Gehrman, PhD; Kevin Williams, MS, MPAS, PA-C
Expert Psych Congress faculty examine how aripiprazole may be used as adjunctive treatment for MDD.
Expert Psych Congress faculty examine how aripiprazole may be used as adjunctive treatment for MDD.
Expert Psych Congress faculty...
07/28/2026
Psych Congress Network

From the Newsrooms

Mariela Podolski, MD, and James Somers, PA-C, DHSc, DFAAPA
Videos
Exploring the Biological Role of Nutrition in Mental Health Care
10/22/2026
Mariela Podolski, MD; James C. Somers, DHSc, PA-C, DFAAPA
Psych Congress faculty members Mariela Podolski, MD, and James Somers, PA-C, DHSc, DFAAPA, discuss the relationship between nutrition and psychiatric outcomes.
Psych Congress faculty members Mariela Podolski, MD, and James Somers, PA-C, DHSc, DFAAPA, discuss the relationship between nutrition and psychiatric outcomes.
Psych Congress faculty members...
10/22/2026
Psych Congress Network
Kristian Dambrino, DNP, PMHNP-BC
Clinical Pearls
Exploring the Role of Dual-Mechanism and Multimodal Antidepressants in MDD Treatment
10/13/2026
Kristian Dambrino, DNP, APRN, MSN
Kristian Dambrino, DNP, PMHNP-BC, explores the role that dual-mechanism and multimodal medications may play in individualized major depressive disorder (MDD) care.
Kristian Dambrino, DNP, PMHNP-BC, explores the role that dual-mechanism and multimodal medications may play in individualized major depressive disorder (MDD) care.
Kristian Dambrino, DNP,...
10/13/2026
Psych Congress NP Institute
Kristian Dambrino, DNP, PMHNP-BC
Conference Insights
Refining the Diagnosis When MDD Treatment Falls Short
10/05/2026
Kristian Dambrino, DNP, PMHNP, MSN
Kristian Dambrino, DNP, PMHNP-BC, offers a framework for pinpointing when antidepressant nonresponse in MDD may be a byproduct of misdiagnosis.
Kristian Dambrino, DNP, PMHNP-BC, offers a framework for pinpointing when antidepressant nonresponse in MDD may be a byproduct of misdiagnosis.
Kristian Dambrino, DNP,...
10/05/2026
Psych Congress Network
Michael Asbach, DMsc, PA-C
Conference Insights
Rethinking MDD Through Glutamate and Neuroplasticity
09/22/2026
Michael Asbach, DMSc, PA-C
Michael Asbach, DMSc, PA-C, Clinical Editor, Psych Congress Journal, explores key concepts from his Psych Congress 2026 session, “Could Glutamatergic Modulation be the Keystone of Durable Change in Treatment-Resistant Depression?”
Michael Asbach, DMSc, PA-C, Clinical Editor, Psych Congress Journal, explores key concepts from his Psych Congress 2026 session, “Could Glutamatergic Modulation be the Keystone of Durable Change in Treatment-Resistant Depression?”
Michael Asbach, DMSc, PA-C,...
09/22/2026
Psych Congress Network
Vladimir Maletic presents on stage
Videos
Dr Vladimir Maletic Memorial Scholarship Recipient Reflects on His Legacy of Compassionate, Patient-Centered Care
09/19/2026
The Dr Vladimir Maletic Memorial Scholarship was established to honor the life, legacy, and lasting influence of Dr Vladimir Maletic, a beloved member of the Psych Congress community and exceptional clinician and educator.
The Dr Vladimir Maletic Memorial Scholarship was established to honor the life, legacy, and lasting influence of Dr Vladimir Maletic, a beloved member of the Psych Congress community and exceptional clinician and educator.
The Dr Vladimir Maletic Memorial...
09/19/2026
Psych Congress Network
rows of pill bottles
Conference Coverage
Lumateperone Improves Acute Mania Symptoms, Trial Results Presented at Psych Congress
09/18/2026
Maria Mantas
Lumateperone significantly improved symptoms of acute mania in patients with bipolar I disorder with or without mixed features compared with placebo, according to data presented at Psych Congress.
Lumateperone significantly improved symptoms of acute mania in patients with bipolar I disorder with or without mixed features compared with placebo, according to data presented at Psych Congress.
Lumateperone significantly...
09/18/2026
Psych Congress Network
Julie Carbray, PhD, PMHNP-BC, and James Greenblatt, MD
Videos
First-Line Decisions in ADHD: Lifestyle Modification or Medication?
09/18/2026
Julie Carbray PhD, PMHNP-BC, PMHCNS-BC, FAAN; James Greenblatt, MD
Julie Carbray, PhD, PMHNP-BC, FAAN, and James Greenblatt, MD, discuss how functional impairment, symptom severity, patient preferences, life stage, and family perspectives can shape initial ADHD treatment decisions, as explored at their 2026...
Julie Carbray, PhD, PMHNP-BC, FAAN, and James Greenblatt, MD, discuss how functional impairment, symptom severity, patient preferences, life stage, and family perspectives can shape initial ADHD treatment decisions, as explored at their 2026...
Julie Carbray, PhD, PMHNP-BC,...
09/18/2026
Psych Congress Network
a man unable to sleep and a digital clock displaying 3:24 am
Conference Coverage
Putting Sleep at the Center of Mental Health Care at Psych Congress 2026
09/17/2026
Maria Mantas
Several sessions at Psych Congress 2026 explore sleep symptoms in psychiatric illness, clinical considerations across the lifespan, and the role psychiatric clinicians can play in identifying and treating sleep-wake disorders.
Several sessions at Psych Congress 2026 explore sleep symptoms in psychiatric illness, clinical considerations across the lifespan, and the role psychiatric clinicians can play in identifying and treating sleep-wake disorders.
Several sessions at Psych...
09/17/2026
Psych Congress Network
Paul Weigle, MD.
Q&A
When Coping Becomes Avoidance: Technology Use in Anxious Youth
09/17/2026
Paul Weigle, MD
Paul Weigle, MD, Associate Medical Director of Ambulatory Programs, Natchaug Hospital, discusses how clinicians can identify problematic technology use, assess its effects on functioning, and understand the psychological needs driving screen...
Paul Weigle, MD, Associate Medical Director of Ambulatory Programs, Natchaug Hospital, discusses how clinicians can identify problematic technology use, assess its effects on functioning, and understand the psychological needs driving screen...
Paul Weigle, MD, Associate...
09/17/2026
Psych Congress Network
poster hall at a conference
Conference Coverage
AI-Clinician Treatment Concordance Linked to Better Psychiatry Outcomes
09/16/2026
Brionna Mendoza
Greater concordance between clinical decisions and recommendations from an artificial intelligence clinical decision support system (AI-CDSS) was associated with better 12-month outcomes among psychiatric outpatients.
Greater concordance between clinical decisions and recommendations from an artificial intelligence clinical decision support system (AI-CDSS) was associated with better 12-month outcomes among psychiatric outpatients.
Greater concordance between...
09/16/2026
Psych Congress Network

Quizzes

Rakesh Jain, MD, MPH
Quiz
Common Missteps in Sleep Care
10/13/2026
Maria Mantas
According to an interview with Rakesh Jain, MD, MPH, what is a common mistake clinicians make when evaluating sleep complaints in patients with psychiatric disorders?
According to an interview with Rakesh Jain, MD, MPH, what is a common mistake clinicians make when evaluating sleep complaints in patients with psychiatric disorders?
According to an interview with...
10/13/2026
Psych Congress Network
illustration of a laptop screen displaying a test
Quiz
Biomarker-Consistent Antidepressant Selection
10/13/2026
Maria Mantas
Can you recall how biomarker-consistent antidepressant treatment compared to biomarker-inconsistent treatment?
Can you recall how biomarker-consistent antidepressant treatment compared to biomarker-inconsistent treatment?
Can you recall how...
10/13/2026
Psych Congress Network
pencil erasers that spell out the word "quiz"
Quiz
iTBS Outcomes in MDD
09/15/2026
Maria Mantas
Can you recall how iBTS compared to sham in addressing clinician-rated depressive symptoms among adults with MDD?
Can you recall how iBTS compared to sham in addressing clinician-rated depressive symptoms among adults with MDD?
Can you recall how iBTS compared...
09/15/2026
Psych Congress Network
Pop quiz written on a blackboard with white chalk
Quiz
rTMS Function in MDD Treatment
09/09/2026
Brionna Mendoza
Test your treatment knowledge with this quiz!
Test your treatment knowledge with this quiz!
Test your treatment knowledge...
09/09/2026
Psych Congress Network
Craig Chepke, MD, DFAPA
Quiz
Assessing VMAT2 Inhibitor Response
09/03/2026
Maria Mantas
Test your knowledge of VMAT2 inhibitor dosing!
Test your knowledge of VMAT2 inhibitor dosing!
Test your knowledge of VMAT2...
09/03/2026
Psych Congress Network
Craig Chepke, MD, DFAPA
Quiz
Assessing VMAT2 Inhibitor Response
09/03/2026
Maria Mantas
Test your knowledge of VMAT2 inhibitor dosing!
Test your knowledge of VMAT2 inhibitor dosing!
Test your knowledge of VMAT2...
09/03/2026
Psych Congress Network
an illustrated laptop screen displaying a quiz
Quiz
Adjunctive Treatment Efficacy in MDD
08/26/2026
Maria Mantas
Can you recall which drug demonstrated the highest efficacy as adjunctive therapy for major depressive disorder?
Can you recall which drug demonstrated the highest efficacy as adjunctive therapy for major depressive disorder?
Can you recall which drug...
08/26/2026
Psych Congress Network
pencil erasers that spell out the word "quiz"
Quiz
Citalopram Dosing in Older Adults
08/25/2026
Maria Mantas
What is the recommended dosage of citalopram for older patients? Test your prescribing knowledge with this quiz!
What is the recommended dosage of citalopram for older patients? Test your prescribing knowledge with this quiz!
What is the recommended dosage...
08/25/2026
Psych Congress Network
Chelsie Monroe Expert Insights Quiz
Expert Insights Quiz
Distinguishing EDS From Fatigue
08/03/2026
Maria Mantas
What key characteristics can help clinicians differentiate fatigue from excessive daytime sleepiness in clinical practice?
What key characteristics can help clinicians differentiate fatigue from excessive daytime sleepiness in clinical practice?
What key characteristics can...
08/03/2026
Psych Congress Network
a printed test, pencil, and clock on a desk
Quiz
Pharmacologic Treatment for Adolescent MDD
07/23/2026
Maria Mantas
Can you recall what the APA guideline recommends? Test yourself with this quick quiz!
Can you recall what the APA guideline recommends? Test yourself with this quick quiz!
Can you recall what the APA...
07/23/2026
Psych Congress Network

Recent FDA Updates

FDA building
FDA Approval
FDA Approves Centanafadine for Pediatric and Adult ADHD
07/27/2026
Maria Mantas
The US Food and Drug Administration (FDA) has approved centanafadine (SIMTRIYO), a norepinephrine, dopamine, serotonin reuptake inhibitor (NDSRI), for the treatment of attention-deficit/hyperactivity disorder (ADHD).
The US Food and Drug Administration (FDA) has approved centanafadine (SIMTRIYO), a norepinephrine, dopamine, serotonin reuptake inhibitor (NDSRI), for the treatment of attention-deficit/hyperactivity disorder (ADHD).
The US Food and Drug...
07/27/2026
Psych Congress Network
FDA approval stamp
FDA Alerts
FDA Accepts NDA for AXS-12 in Cataplexy Associated With Narcolepsy
07/16/2026
Maria Mantas
The US Food and Drug Administration (FDA) accepted Axsome Therapeutics’ New Drug Application (NDA) for AXS-12 (reboxetine) for cataplexy in narcolepsy.
The US Food and Drug Administration (FDA) accepted Axsome Therapeutics’ New Drug Application (NDA) for AXS-12 (reboxetine) for cataplexy in narcolepsy.
The US Food and Drug...
07/16/2026
Psych Congress Network
Food and Drug Administration building
News
FDA Approves Milsaperidone for Bipolar I and Schizophrenia in Adults
02/24/2026
Maria Mantas
The FDA has approved milsaperidone for the treatment of schizophrenia in adults and for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.
The FDA has approved milsaperidone for the treatment of schizophrenia in adults and for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.
The FDA has approved...
02/24/2026
Psych Congress Network
US FDA building
News
FDA Requests Removal of Suicide Risk Warnings From GLP-1 RA Labels
01/14/2026
Maria Mantas
The US Food and Drug Administration (FDA) has requested the removal of information regarding the risk of suicidal ideation and behaviors (SI/B) from the labeling of glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications.
The US Food and Drug Administration (FDA) has requested the removal of information regarding the risk of suicidal ideation and behaviors (SI/B) from the labeling of glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications.
The US Food and Drug...
01/14/2026
Psych Congress Network
FDA building
News
FDA Approves At-Home Neuromodulation Therapy Device for Major Depression
01/12/2026
Maria Mantas
The US Food and Drug Administration has approved Proliv™Rx, a novel at-home neuromodulation therapy as adjunctive treatment for adults with major depressive disorder (MDD).
The US Food and Drug Administration has approved Proliv™Rx, a novel at-home neuromodulation therapy as adjunctive treatment for adults with major depressive disorder (MDD).
The US Food and Drug...
01/12/2026
Psych Congress Network
FDA approval stamp
News
FDA Approves First At-Home tDCS Treatment for Major Depressive Disorder
12/16/2025
Maria Mantas
The US Food and Drug Administration (FDA) has approved the first at-home transcranial direct current stimulation (tDCS) device for the treatment of moderate to severe major depressive disorder (MDD).
The US Food and Drug Administration (FDA) has approved the first at-home transcranial direct current stimulation (tDCS) device for the treatment of moderate to severe major depressive disorder (MDD).
The US Food and Drug...
12/16/2025
Psych Congress Network
FDA approval stamp
News
FDA Approves Lumateperone Indication for Major Depressive Disorder
11/07/2025
Maria Mantas
The US Food and Drug Administration (FDA) has approved lumateperone (CAPLYTA®) as an adjunctive therapy with antidepressants for the treatment of major depressive disorder (MDD) in adults.
The US Food and Drug Administration (FDA) has approved lumateperone (CAPLYTA®) as an adjunctive therapy with antidepressants for the treatment of major depressive disorder (MDD) in adults.
The US Food and Drug...
11/07/2025
Psych Congress Network
US FDA sign
News
FDA OKs Once Monthly Subcutaneous Risperidone for Bipolar I Disorder
10/20/2025
Brionna Mendoza
The US Food and Drug Administration (FDA) has approved risperidone (Uzedy) as a once-monthly extended-release injectable suspension for the treatment of bipolar I disorder (BD-I).
The US Food and Drug Administration (FDA) has approved risperidone (Uzedy) as a once-monthly extended-release injectable suspension for the treatment of bipolar I disorder (BD-I).
The US Food and Drug...
10/20/2025
Psych Congress Network
fda building sign
News
FDA Approves TMS Device for Major Depressive Disorder in Adolescents
09/11/2025
Brionna Mendoza
The US Food and Drug Administration (FDA) approved on Wednesday the Apollo Transcranial Magnetic Stimulation (TMS) Therapy devices for the adjunctive treatment of major depressive disorder (MDD) in adolescents.
The US Food and Drug Administration (FDA) approved on Wednesday the Apollo Transcranial Magnetic Stimulation (TMS) Therapy devices for the adjunctive treatment of major depressive disorder (MDD) in adolescents.
The US Food and Drug...
09/11/2025
Psych Congress Network
FDA building
News
FDA Advisory Committee Votes Against Brexpiprazole Indication for Treatment of PTSD Following Efficacy Concerns
07/21/2025
Maria Mantas
The US Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee voted not to recommend the use of brexpiprazole in combination with sertraline for the treatment of posttraumatic stress disorder (PTSD).  
The US Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee voted not to recommend the use of brexpiprazole in combination with sertraline for the treatment of posttraumatic stress disorder (PTSD).  
The US Food and Drug...
07/21/2025
Psych Congress Network

Live Meetings

Psych Congress Family & Friends Podcast

Rakesh Jain and Craig Chepke
Podcasts
Psych Congress Family & Friends Podcast, Episode 8: Beyond the Headlines: The Good, The Bad, and The Ugly of SSRIs
10/09/2025
Rakesh Jain, MD, MPH, RD; Craig Chepke, MD, DFAPA; Ragy R. Girgis, MD, MS
In this episode, Drs Rakesh Jain and Craig Chepke are joined by Dr Ragy Girgis of Columbia University to explore the small but important nuances around antidepressants, black box warnings, and violence risk in untreated psychosis.
In this episode, Drs Rakesh Jain and Craig Chepke are joined by Dr Ragy Girgis of Columbia University to explore the small but important nuances around antidepressants, black box warnings, and violence risk in untreated psychosis.
In this episode, Drs Rakesh Jain...
10/09/2025
Psych Congress Network
Craig Chepke and Rakesh Jain
Podcasts
Psych Congress Family & Friends Podcast, Episode 7: Sleep is the Foundation of Mental Health
09/12/2025
Craig Chepke, MD, DFAPA; Rakesh Jain, MD, MPH, RD
Sleep–wake disorders are clinically significant and too often overlooked in psychiatric practice. Drs. Rakesh Jain and Craig Chepke share practical strategies for recognizing and treating insomnia, hypersomnia, and obstructive sleep apnea.
Sleep–wake disorders are clinically significant and too often overlooked in psychiatric practice. Drs. Rakesh Jain and Craig Chepke share practical strategies for recognizing and treating insomnia, hypersomnia, and obstructive sleep apnea.
Sleep–wake disorders are...
09/12/2025
Psych Congress Network
Rakesh Jain and Craig Chepke
Podcasts
Psych Congress Family & Friends Podcast, Episode 6: Psychiatry Is the Specialty That Speaks for Those Without a Voice
09/08/2025
Rakesh Jain, MD, MPH, RD; Craig Chepke, MD, DFAPA
In this episode, Drs Rakesh Jain and Craig Chepke explore why fibromyalgia belongs in psychiatry’s wheelhouse and address the stigma patients face every day.
In this episode, Drs Rakesh Jain and Craig Chepke explore why fibromyalgia belongs in psychiatry’s wheelhouse and address the stigma patients face every day.
In this episode, Drs Rakesh Jain...
09/08/2025
Psych Congress Network
Craig Chepke and Rakesh Jain
Podcasts
Psych Congress Family & Friends Podcast, Episode 5: We’re Too Addicted to Our Own Good Ideas
08/25/2025
Craig Chepke, MD, DFAPA; Rakesh Jain, MD, MPH, RD
In this episode, Drs Rakesh Jain and Craig Chepke reflect on how the words we use—and the habits we form—shape the way we practice. The pair also take a fresh look at the serotonin story, talk through new ways of understanding depression, and...
In this episode, Drs Rakesh Jain and Craig Chepke reflect on how the words we use—and the habits we form—shape the way we practice. The pair also take a fresh look at the serotonin story, talk through new ways of understanding depression, and...
In this episode, Drs Rakesh Jain...
08/25/2025
Psych Congress Network
craig chepke and rakesh jain
Podcasts
Psych Congress Family & Friends Podcast, Episode 4: Every Pill is a Choice
07/25/2025
Craig Chepke, MD, DFAPA; Rakesh Jain, MD, MPH, RD
Through a positive psychiatry lens, Drs Rakesh Jain and Craig Chepke reflect on recent research, the challenges of psychiatric diagnosis, and why every treatment decision should begin with a deep understanding of the person in front of us.
Through a positive psychiatry lens, Drs Rakesh Jain and Craig Chepke reflect on recent research, the challenges of psychiatric diagnosis, and why every treatment decision should begin with a deep understanding of the person in front of us.
Through a positive psychiatry...
07/25/2025
Psych Congress Network
Rakesh and Craig
Podcasts
Weighing the Options: Medication, Lifestyle, and the Path to Wellness
03/26/2025
Rakesh Jain, MD, MPH, RD; Craig Chepke, MD, DFAPA
In this episode, Dr Rakesh Jain and Dr Craig Chepke explore medication-induced weight gain in schizophrenia treatment and how clinicians can help patients take control of their health, mind, and body.
In this episode, Dr Rakesh Jain and Dr Craig Chepke explore medication-induced weight gain in schizophrenia treatment and how clinicians can help patients take control of their health, mind, and body.
In this episode, Dr Rakesh Jain...
03/26/2025
Psych Congress Network
psych congress family and friends podcast
Podcasts
Gut Feelings: Tackling Medication-Induced Nausea
02/05/2025
Craig Chepke, MD, DFAPA; Rakesh Jain, MD, MPH, RD
Join Dr Craig Chepke and Dr Rakesh Jain in this episode of the Psych Congress Family & Friends Podcast as they tackle a topic that affects so many patients receiving psychiatric treatment: nausea!
Join Dr Craig Chepke and Dr Rakesh Jain in this episode of the Psych Congress Family & Friends Podcast as they tackle a topic that affects so many patients receiving psychiatric treatment: nausea!
Join Dr Craig Chepke and Dr...
02/05/2025
Psych Congress Network
psych congress family and friends podcast
Podcasts
A New Beginning, and a Fond Farewell
01/06/2025
Craig Chepke, MD, DFAPA; Rakesh Jain, MD, MPH, RD
Join Dr Rakesh Jain and Dr Craig Chepke for a discussion of feelings surrounding the recent passing of Dr Vladimir Maletic leads to an exploration of a topic near and dear to Dr Maletic's heart—the role of norepinephrine in clinical practice.
Join Dr Rakesh Jain and Dr Craig Chepke for a discussion of feelings surrounding the recent passing of Dr Vladimir Maletic leads to an exploration of a topic near and dear to Dr Maletic's heart—the role of norepinephrine in clinical practice.
Join Dr Rakesh Jain and Dr Craig...
01/06/2025
Psych Congress Network
psych congress family and friends podcast
Podcasts
Welcome to Psych Congress Family & Friends Hosted by Rakesh Jain and Craig Chepke
01/06/2025
Rakesh Jain, MD, MPH, RD; Craig Chepke, MD, DFAPA
Introducing our new psychiatry and psychopharmacology podcast aimed at enhancing your clinical practice in an approachable and heartfelt way, hosted by Rakesh Jain, MD, MPH, and Craig Chepke, MD, DFAPA. Subscribe now!
Introducing our new psychiatry and psychopharmacology podcast aimed at enhancing your clinical practice in an approachable and heartfelt way, hosted by Rakesh Jain, MD, MPH, and Craig Chepke, MD, DFAPA. Subscribe now!
Introducing our new psychiatry...
01/06/2025
Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, MSN, APRN, PMHNP-BC
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Insights
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Desiree Matthews, PHMNP-BC; Amber Hoberg, MSN, APRN, PMHNP-BC
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use